Dr. Wezi Kachinda is an early career researcher in the field of infectious diseases and clinical pathology, with a demonstrated history of working in the executive office industry. His field of specialization involve molecular biological evaluation of various disease causing pathogens and non-communicable diseases against the laboratory synthesized drugs/ drug-like molecules and biologically active plant extracts. His recent research led to the first Characterization of Chromosomal Abnormalities in Acute Myeloid Leukaemia (AML) Patients at the University Teaching Hospital, Lusaka, Zambia. The project showed that chromosomal alteration PML/RAR t(15,17) which was 21.4% ,was the commonest鈥�.
We鈥檝e updated our privacy policy so that we are compliant with changing global privacy regulations and to provide you with insight into the limited ways in which we use your data.
You can read the details below. By accepting, you agree to the updated privacy policy.
